Jarrod Longcor insider trades
Open-market stock purchases and sales by Jarrod Longcor, Chief Operating Officer at Cellectar Biosciences, Inc, from SEC Form 4 filings since Jul 15, 2016.
Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +47%.
Companies traded
- CLRB Cellectar Biosciences, Inc: 9 buys, 1 sale, last May 7, 2026